Ntaios, GeorgeGeorgeNtaiosHuisman, Menno VMenno VHuismanDiener, Hans-ChristophHans-ChristophDienerHalperin, Jonathan LJonathan LHalperinTeutsch, ChristineChristineTeutschMarler, SabrinaSabrinaMarlerGurusamy, Venkatesh KVenkatesh KGurusamyThompson, MillaMillaThompsonLip, Gregory Y HGregory Y HLipFU-TIEN CHIANGOlshansky, BrianBrianOlshansky2021-11-292021-11-29202111099666https://scholars.lib.ntu.edu.tw/handle/123456789/588091The SAMe-TT2R2 score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during anticoagulation with vitamin K antagonists (VKA) and those with scores >2 might be better managed with a target-specific oral anticoagulant (NOAC). We hypothesized that in clinical practice, VKAs may be prescribed less frequently to patients with AF and SAMe-TT2R2 scores >2 than to patients with lower scores.enSAMe-TT(2)R(2); atrial fibrillation; non-vitamin-K antagonist oral anticoagulants; vitamin-K-antagonist oral anticoagulants[SDGs]SDG3journal article10.1016/j.hjc.2020.11.009333386442-s2.0-85100117647https://api.elsevier.com/content/abstract/scopus_id/85100117647